Market sentiment signals for AbCellera Biologics (ABCL): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
11 analysts
Options Flow (P/C)
—
Avg Consensus PT
$13
+9.5%
Highest Price Target
$30
+149.2%
Lowest Price Target
$4
-66.8%
Short Interest
12.8%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | UBS | Alice Nettleton— | +49.5% | $18 | Initiate | Buy |
| Sep 29, 2026 | JP Morgan | Brian Cheng— | +41.2% | $17 | Initiate | Overweight |
